MAPT and intrahepatic cholangiocarcinoma: As in ICC observations, a decreased T22 staining was observed when HEK+tauP301S+HS3ST2 cells were compared to HEK+tau+HS3ST2 cells (Fig. 3b–d), suggesting no immunoreactivity of T22 at advanced oligomerisation.